Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| RGNX Historical Stock Prices |
| Preferred Stock Newsletter |
| RGNX Options Chain |
| Stock Message Boards |
REGENXBIO (RGNX) has the following price history information. Looking back at RGNX historical stock prices for the last five trading days, on April 15, 2024, RGNX opened at $18.07, traded as high as $18.65 and as low as $17.82, and closed at $18.02. Trading volume was a total of 346.00K shares. On April 16, 2024, RGNX opened at $17.83, traded as high as $18.24 and as low as $17.48, and closed at $17.50. Trading volume was a total of 296.00K shares. On April 17, 2024, RGNX opened at $17.59, traded as high as $17.99 and as low as $16.99, and closed at $17.03. Trading volume was a total of 413.60K shares. On April 18, 2024, RGNX opened at $16.75, traded as high as $16.82 and as low as $16.05, and closed at $16.11. Trading volume was a total of 560.50K shares. On April 19, 2024, RGNX opened at $16.01, traded as high as $16.26 and as low as $15.32, and closed at $15.69. Trading volume was a total of 574.90K shares.
RGNX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into REGENXBIO shares, starting with a $10,000 purchase of RGNX, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/18/2015 | |
| End date: | 04/19/2024 | |
| Start price/share: | $30.70 | |
| End price/share: | $15.69 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -48.89% | |
| Average Annual Total Return: | -7.52% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $5,108.46 | |
| Years: | 8.59 | |
 | |||||
| RGNX Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 04/15/2024 | $18.07 | $18.65 | $17.82 | $18.02 | 346.00K |
| 04/16/2024 | $17.83 | $18.24 | $17.48 | $17.50 | 296.00K |
| 04/17/2024 | $17.59 | $17.99 | $16.99 | $17.03 | 413.60K |
| 04/18/2024 | $16.75 | $16.82 | $16.05 | $16.11 | 560.50K |
| 04/19/2024 | $16.01 | $16.26 | $15.32 | $15.69 | 574.90K |
|
| About REGENXBIO |
| REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease. |
| RGNX Historical Closing Prices | |
| Date | Close |
| 04/15/2024 | $18.02 |
| 04/16/2024 | $17.50 |
| 04/17/2024 | $17.03 |
| 04/18/2024 | $16.11 |
| 04/19/2024 | $15.69 |
| Healthcare Historical Prices |
| RGNX is categorized under the Healthcare sector; below are some other companies in the same sector:
RHE Historical Stock Prices Also explore: RGNX shares outstanding history
|
Free RGNX Email Alerts:
RGNX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.